Irbesartan
Avapro
Angiotensin 2 Receptor Blocker
NADAC/unit
$0.0843
No Shortage
Tier 1: 203.0%
15 Manufacturers
45 ANDAs
Irbesartan lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.
vs. brand Avapro: Generic saves up to 99% per unit
Market Intelligence
2025-02-19 Class II Recall: AvKARE
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAMNEAL PHARMACEUTICALS OF NEW YORK LLCAUROBINDO PHARMA LTDCHARTWELL MOLECULAR HOLDINGS LLCHETERO LABS LTD UNIT VHISUN PHARMACEUTICAL (HANGZHOU) CO LTDJUBILANT GENERICS LTDMACLEODS PHARMACEUTICALS LTDMSN LABORATORIES PRIVATE LTDPRINSTON PHARMACEUTICAL INCSANDOZ INCSANOFI AVENTIS US LLCSCIEGEN PHARMACEUTICALS INCTEVA PHARMACEUTICALS USAUNICHEM LABORATORIES LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.